1. Bornstein MB, Miller A, Slagle S et al. (1987) A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis. N Engl J Med 317: 408–414
2. British and Dutch Multiple Sclerosis Azathioprine Trial Group (1988) Double-masked trial of azathioprine in multiple sclerosis. Lancet 2: 179–183
3. Broman T (1970) Management of patients with multiple sclerosis. In: Vinken PJ, Bruyn GW (eds) Multiple sclerosis and other demyelinating diseases. North-Holland Publishing Company, Amsterdam, pp 408–425 (Handbook of clinical neurology, vol 9 )
4. Brown JR, Beebe GW, Kurtzke JF, Loewenson RB, Silberberg DH, Tourtellotte WW (1979) The design of clinical studies to assess therapeutic efficacy in multiple sclerosis. Neurology 29: 1–23
5. Detels R, Clark VA, Valdiviezo NL, Visscher BR, Malmgren RM, Dudley JP (1982) Factors associated with a rapid course of multiple sclerosis. Arch Neurol 39: 337–341